Agenda & Learning Objectives

Participants in this program will:

  • Explore current and future IBD therapies and mechanisms of action
  • Consider current and future diagnostic and therapeutic applications for genetics in IBD
  • Integrate basic science and clinical practice by participating in a choice of workshops to:
    • Review the current fidnings of the IMAGINE study
    • Develop an understanding of current and novel complementary medicines in IBD
    • Consider the latest research in nutrition and IBD
    • Examine technology for diagnostic and therapeutic applications in IBD
  • Examine the evolving role of complementary medicine in the treatment of IBD

NOTE: Junior Investigator Award – Please go to the Call for Abstracts page on the registration site

Time Title/Topic Speakers

0.1 Welcome 
Nurse of the Year Award, Physician of the Year Award, CCC-Pfizer Women in IBD Emerging Researcher Award, CCC-Pfizer Women in IBD Outstanding Researcher Award

Lori Radke
CEO, Crohn's and Colitis Canada
08:50 0.2 Opening Remarks – Welcome, program objectives 
Remo Panaccione & Hillary Steinhart
09:00 0.3 Overview of the GEM Project (15 mins) Kenneth Croitoru

Session I: New Therapies in Combination

Laura Targownik
09:15 1.1 Plenary Presentation
Emerging Therapies: What, where, why and when
Brian Feagan
9:35 1.2 Plenary Presentation
Mechanisms: New Therapies
Stefan Schreiber

1.3 Ask-the Expert Panel Session

MODERATOR: Laura Targownik
PANEL: Brian Feagan, Vivian Huang, Stefan Schreiber

1.4 Junior Investigator Award & Presentation

10:35 Refreshment Break (15 minutes)  

Session II: Genetics in IBD

SESSION CHAIR: Heather Armstrong
10:50 2.1 Plenary Presentation
Genetics in IBD: Where are we now?
Mark Silverberg
11:10 2.2 Plenary Presentation
Beyond Genetics: What is next?
John Rioux
11:30 2.3 Ask-the Expert Panel Session MODERATOR: Heather Armstrong
PANEL: Sally Lawrence, John Rioux, Mark Silverberg
11:50 2.4 Rising Star Award & Presentation (title TBA) TBA
12:10 Lunch Break (60 minutes)  

Session III: Workshops – Hot Topics from Bench to Policy

13:10 Placement into Workshops  
13:15 3.1 Workshop
IMAGINE Study Update
Deborah Marshall & Paul Moayyedi
3.2 Workshop
Complementary Medicine and IBD
Nir Solomon
3.3 Workshop
Nutrition and IBD
Genelle Lunken & Eytan Wine
3.4 Workshop
Technology: AI and IBD
Michael Byrne & Kerri Novak
14:00 Grab and Go Break (5 minutes)  

Session IV: Revisiting Complementary Approaches in IBD

ELena Verdu
14:05 4.0 Research Leadership Award & Presentation TBA
14:25 4.1 Plenary Presentation
Evidence and Evolution of Complementary Medicine
Nir Solomon
14:45 4.2 Plenary Presentation
Nutrition from Bench to Bedside
Eytan Wine
15:05 4.3 Ask-the Expert Panel Session MODERATOR: Elena Verdu
PANEL: Maitreyi Raman, Nir Solomon, Eytan Wine
15:25 Closing Remarks and Program Evaluation CO-CHAIRS: 
Remo Panaccione & Hillary Steinhart

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.